Zymeworks BC Long Term Debt

Zymeworks BC (ZYME) currently reports a long-term debt of $14B as of March 2026. That compares with $15M in the prior-year period — up 90434.1% year over year. Use the charts on this page to explore Zymeworks BC's long-term debt history and peer comparisons.

Zymeworks BC's long-term debt increased from $15M to $14B — a 90434.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zymeworks BC reported $14B in long-term debt as of March 2026. That compares with $15M in the prior-year period — up 90434.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymeworks BC, and consider following ZYME for alerts when major investors trade the stock.

Zymeworks BC is classified in the Healthcare sector. On long-term debt, it currently shows $14B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZYME with unrelated industries.